Multiplex Ligation-Dependent Probe Amplification Assay for Simultaneous Detection of Parkinson's Disease Gene Rearrangements
Identifieur interne : 001444 ( PascalFrancis/Corpus ); précédent : 001443; suivant : 001445Multiplex Ligation-Dependent Probe Amplification Assay for Simultaneous Detection of Parkinson's Disease Gene Rearrangements
Auteurs : Oronzo Scarciolla ; Francesco Brancati ; Enza Maria Valente ; Alessandro Ferraris ; Maria Vittoria De Angelis ; Stefano Valbonesi ; Barbara Garavaglia ; Antonino Uncini ; Giandomenico Palka ; Liborio Stuppia ; Bruno DallapiccolaSource :
- Movement disorders [ 0885-3185 ] ; 2007.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
:Parkinson's disease (PD) is a common disorder caused by degeneration of dopaminergic neurons in the substantia nigra and other brain areas. Mutations in several genes have been associated with both autosomal dominant PD and recessive early onset Parkinsonism (EOP). Genomic rearrangements such as deletions or multiplications of one or more exons represent a common mutational mechanism for most of these genes and are not detectable with routine mutation screening techniques. MLPA (Multiplex Ligation-dependent Probe Amplification), is a cheap, simple, rapid, and sensitive tool to detect exon dosage alterations and specific point mutations in selected genes. We tested the recently developed PD-MLPA assay by using 13 positive control samples carrying known mutations in SNCA, LRRK2, Parkin, PINK1, and DJ-1 genes. We then applied this technique to screen 16 EOP patients who were then cross-tested by quantitative PCR (qPCR). All the mutations present in the positive control samples were clearly detected by MLPA. Moreover, three novel Parkin rearrangements were identified among EOP patients and confirmed by qPCR. Only two samples generated false positive duplications of LRRK2 exon 1 and UCH-L1 exon 9, respectively. These results show that PD-MLPA assay can simultaneously and effectively detect rearrangements in most PD genes (SNCA, Parkin, PINK1, and DJ-1) as well as the LRRK2 G2019S common mutation. Thus, the use of this novel platform can improve the analysis of such mutations, facilitating comprehensive genetic testing in PD and EOP.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
|
---|
Format Inist (serveur)
NO : | PASCAL 08-0071417 INIST |
---|---|
ET : | Multiplex Ligation-Dependent Probe Amplification Assay for Simultaneous Detection of Parkinson's Disease Gene Rearrangements |
AU : | SCARCIOLLA (Oronzo); BRANCATI (Francesco); VALENTE (Enza Maria); FERRARIS (Alessandro); VITTORIA DE ANGELIS (Maria); VALBONESI (Stefano); GARAVAGLIA (Barbara); UNCINI (Antonino); PALKA (Giandomenico); STUPPIA (Liborio); DALLAPICCOLA (Bruno) |
AF : | Aging Research Center, CeSi, University G. d'Annunzio/Chieti/Italie (1 aut., 2 aut., 6 aut., 9 aut., 10 aut.); Department of Biomedical Sciences, University G. d'Annunzio/Chieti/Italie (1 aut., 2 aut., 6 aut., 9 aut., 10 aut.); Department of Clinical Sciences and Bioimaging, University G. d'Annunzio/Chieti-Pescara/Italie (1 aut.); IRCCS CSS-Mendel Institute/Rome/Italie (2 aut., 3 aut., 4 aut., 11 aut.); Operative Unit of Pediatric Genetics and Immunology, Department of Medical and Surgical Pediatric Sciences, University of Messina/Messina/Italie (3 aut., 11 aut.); Department of Experimental Medicine and Pathology, University La Sapienza/Rome/Italie (4 aut.); Neurodegenerative Diseases Unit, Aging Research Center, CeSi, University G. d'Annunzio/Chieti/Italie (5 aut., 8 aut.); Department of Human Motor Sciences, University G. d'Annunzio/Chieti/Italie (5 aut., 8 aut.); Molecular Neurogenetics Unit, Foundation IRCCS Neurological Institute "C. Besta"/Milan/Italie (7 aut.); Human Genetics Division, Hospital of Pescara/Pescara/Italie (9 aut.); IGM CNR/Bologna/Italie (10 aut.) |
DT : | Publication en série; Courte communication, note brève; Niveau analytique |
SO : | Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2007; Vol. 22; No. 15; Pp. 2274-2278; Bibl. 13 ref. |
LA : | Anglais |
EA : | :Parkinson's disease (PD) is a common disorder caused by degeneration of dopaminergic neurons in the substantia nigra and other brain areas. Mutations in several genes have been associated with both autosomal dominant PD and recessive early onset Parkinsonism (EOP). Genomic rearrangements such as deletions or multiplications of one or more exons represent a common mutational mechanism for most of these genes and are not detectable with routine mutation screening techniques. MLPA (Multiplex Ligation-dependent Probe Amplification), is a cheap, simple, rapid, and sensitive tool to detect exon dosage alterations and specific point mutations in selected genes. We tested the recently developed PD-MLPA assay by using 13 positive control samples carrying known mutations in SNCA, LRRK2, Parkin, PINK1, and DJ-1 genes. We then applied this technique to screen 16 EOP patients who were then cross-tested by quantitative PCR (qPCR). All the mutations present in the positive control samples were clearly detected by MLPA. Moreover, three novel Parkin rearrangements were identified among EOP patients and confirmed by qPCR. Only two samples generated false positive duplications of LRRK2 exon 1 and UCH-L1 exon 9, respectively. These results show that PD-MLPA assay can simultaneously and effectively detect rearrangements in most PD genes (SNCA, Parkin, PINK1, and DJ-1) as well as the LRRK2 G2019S common mutation. Thus, the use of this novel platform can improve the analysis of such mutations, facilitating comprehensive genetic testing in PD and EOP. |
CC : | 002B17; 002B17G; 002B17A03 |
FD : | Pathologie du système nerveux; Maladie de Parkinson; Parkinsonisme; Amplification; Mesure simultanée; Réarrangement génique |
FG : | Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du système nerveux central |
ED : | Nervous system diseases; Parkinson disease; Parkinsonism; Amplification; Simultaneous measurement; Gene rearrangement |
EG : | Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease |
SD : | Sistema nervioso patología; Parkinson enfermedad; Parkinson síndrome; Amplificación; Medición simultánea; Redisposición génica |
LO : | INIST-20953.354000162671070210 |
ID : | 08-0071417 |
Links to Exploration step
Pascal:08-0071417Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Multiplex Ligation-Dependent Probe Amplification Assay for Simultaneous Detection of Parkinson's Disease Gene Rearrangements</title>
<author><name sortKey="Scarciolla, Oronzo" sort="Scarciolla, Oronzo" uniqKey="Scarciolla O" first="Oronzo" last="Scarciolla">Oronzo Scarciolla</name>
<affiliation><inist:fA14 i1="01"><s1>Aging Research Center, CeSi, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Department of Biomedical Sciences, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>Department of Clinical Sciences and Bioimaging, University G. d'Annunzio</s1>
<s2>Chieti-Pescara</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Brancati, Francesco" sort="Brancati, Francesco" uniqKey="Brancati F" first="Francesco" last="Brancati">Francesco Brancati</name>
<affiliation><inist:fA14 i1="01"><s1>Aging Research Center, CeSi, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Department of Biomedical Sciences, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="04"><s1>IRCCS CSS-Mendel Institute</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Valente, Enza Maria" sort="Valente, Enza Maria" uniqKey="Valente E" first="Enza Maria" last="Valente">Enza Maria Valente</name>
<affiliation><inist:fA14 i1="04"><s1>IRCCS CSS-Mendel Institute</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="05"><s1>Operative Unit of Pediatric Genetics and Immunology, Department of Medical and Surgical Pediatric Sciences, University of Messina</s1>
<s2>Messina</s2>
<s3>ITA</s3>
<sZ>3 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ferraris, Alessandro" sort="Ferraris, Alessandro" uniqKey="Ferraris A" first="Alessandro" last="Ferraris">Alessandro Ferraris</name>
<affiliation><inist:fA14 i1="04"><s1>IRCCS CSS-Mendel Institute</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="06"><s1>Department of Experimental Medicine and Pathology, University La Sapienza</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Vittoria De Angelis, Maria" sort="Vittoria De Angelis, Maria" uniqKey="Vittoria De Angelis M" first="Maria" last="Vittoria De Angelis">Maria Vittoria De Angelis</name>
<affiliation><inist:fA14 i1="07"><s1>Neurodegenerative Diseases Unit, Aging Research Center, CeSi, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="08"><s1>Department of Human Motor Sciences, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Valbonesi, Stefano" sort="Valbonesi, Stefano" uniqKey="Valbonesi S" first="Stefano" last="Valbonesi">Stefano Valbonesi</name>
<affiliation><inist:fA14 i1="01"><s1>Aging Research Center, CeSi, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Department of Biomedical Sciences, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Garavaglia, Barbara" sort="Garavaglia, Barbara" uniqKey="Garavaglia B" first="Barbara" last="Garavaglia">Barbara Garavaglia</name>
<affiliation><inist:fA14 i1="09"><s1>Molecular Neurogenetics Unit, Foundation IRCCS Neurological Institute "C. Besta"</s1>
<s2>Milan</s2>
<s3>ITA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Uncini, Antonino" sort="Uncini, Antonino" uniqKey="Uncini A" first="Antonino" last="Uncini">Antonino Uncini</name>
<affiliation><inist:fA14 i1="07"><s1>Neurodegenerative Diseases Unit, Aging Research Center, CeSi, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="08"><s1>Department of Human Motor Sciences, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Palka, Giandomenico" sort="Palka, Giandomenico" uniqKey="Palka G" first="Giandomenico" last="Palka">Giandomenico Palka</name>
<affiliation><inist:fA14 i1="01"><s1>Aging Research Center, CeSi, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Department of Biomedical Sciences, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="10"><s1>Human Genetics Division, Hospital of Pescara</s1>
<s2>Pescara</s2>
<s3>ITA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Stuppia, Liborio" sort="Stuppia, Liborio" uniqKey="Stuppia L" first="Liborio" last="Stuppia">Liborio Stuppia</name>
<affiliation><inist:fA14 i1="01"><s1>Aging Research Center, CeSi, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Department of Biomedical Sciences, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="11"><s1>IGM CNR</s1>
<s2>Bologna</s2>
<s3>ITA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Dallapiccola, Bruno" sort="Dallapiccola, Bruno" uniqKey="Dallapiccola B" first="Bruno" last="Dallapiccola">Bruno Dallapiccola</name>
<affiliation><inist:fA14 i1="04"><s1>IRCCS CSS-Mendel Institute</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="05"><s1>Operative Unit of Pediatric Genetics and Immunology, Department of Medical and Surgical Pediatric Sciences, University of Messina</s1>
<s2>Messina</s2>
<s3>ITA</s3>
<sZ>3 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">08-0071417</idno>
<date when="2007">2007</date>
<idno type="stanalyst">PASCAL 08-0071417 INIST</idno>
<idno type="RBID">Pascal:08-0071417</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001444</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Multiplex Ligation-Dependent Probe Amplification Assay for Simultaneous Detection of Parkinson's Disease Gene Rearrangements</title>
<author><name sortKey="Scarciolla, Oronzo" sort="Scarciolla, Oronzo" uniqKey="Scarciolla O" first="Oronzo" last="Scarciolla">Oronzo Scarciolla</name>
<affiliation><inist:fA14 i1="01"><s1>Aging Research Center, CeSi, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Department of Biomedical Sciences, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>Department of Clinical Sciences and Bioimaging, University G. d'Annunzio</s1>
<s2>Chieti-Pescara</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Brancati, Francesco" sort="Brancati, Francesco" uniqKey="Brancati F" first="Francesco" last="Brancati">Francesco Brancati</name>
<affiliation><inist:fA14 i1="01"><s1>Aging Research Center, CeSi, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Department of Biomedical Sciences, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="04"><s1>IRCCS CSS-Mendel Institute</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Valente, Enza Maria" sort="Valente, Enza Maria" uniqKey="Valente E" first="Enza Maria" last="Valente">Enza Maria Valente</name>
<affiliation><inist:fA14 i1="04"><s1>IRCCS CSS-Mendel Institute</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="05"><s1>Operative Unit of Pediatric Genetics and Immunology, Department of Medical and Surgical Pediatric Sciences, University of Messina</s1>
<s2>Messina</s2>
<s3>ITA</s3>
<sZ>3 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ferraris, Alessandro" sort="Ferraris, Alessandro" uniqKey="Ferraris A" first="Alessandro" last="Ferraris">Alessandro Ferraris</name>
<affiliation><inist:fA14 i1="04"><s1>IRCCS CSS-Mendel Institute</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="06"><s1>Department of Experimental Medicine and Pathology, University La Sapienza</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Vittoria De Angelis, Maria" sort="Vittoria De Angelis, Maria" uniqKey="Vittoria De Angelis M" first="Maria" last="Vittoria De Angelis">Maria Vittoria De Angelis</name>
<affiliation><inist:fA14 i1="07"><s1>Neurodegenerative Diseases Unit, Aging Research Center, CeSi, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="08"><s1>Department of Human Motor Sciences, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Valbonesi, Stefano" sort="Valbonesi, Stefano" uniqKey="Valbonesi S" first="Stefano" last="Valbonesi">Stefano Valbonesi</name>
<affiliation><inist:fA14 i1="01"><s1>Aging Research Center, CeSi, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Department of Biomedical Sciences, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Garavaglia, Barbara" sort="Garavaglia, Barbara" uniqKey="Garavaglia B" first="Barbara" last="Garavaglia">Barbara Garavaglia</name>
<affiliation><inist:fA14 i1="09"><s1>Molecular Neurogenetics Unit, Foundation IRCCS Neurological Institute "C. Besta"</s1>
<s2>Milan</s2>
<s3>ITA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Uncini, Antonino" sort="Uncini, Antonino" uniqKey="Uncini A" first="Antonino" last="Uncini">Antonino Uncini</name>
<affiliation><inist:fA14 i1="07"><s1>Neurodegenerative Diseases Unit, Aging Research Center, CeSi, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="08"><s1>Department of Human Motor Sciences, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Palka, Giandomenico" sort="Palka, Giandomenico" uniqKey="Palka G" first="Giandomenico" last="Palka">Giandomenico Palka</name>
<affiliation><inist:fA14 i1="01"><s1>Aging Research Center, CeSi, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Department of Biomedical Sciences, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="10"><s1>Human Genetics Division, Hospital of Pescara</s1>
<s2>Pescara</s2>
<s3>ITA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Stuppia, Liborio" sort="Stuppia, Liborio" uniqKey="Stuppia L" first="Liborio" last="Stuppia">Liborio Stuppia</name>
<affiliation><inist:fA14 i1="01"><s1>Aging Research Center, CeSi, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Department of Biomedical Sciences, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="11"><s1>IGM CNR</s1>
<s2>Bologna</s2>
<s3>ITA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Dallapiccola, Bruno" sort="Dallapiccola, Bruno" uniqKey="Dallapiccola B" first="Bruno" last="Dallapiccola">Bruno Dallapiccola</name>
<affiliation><inist:fA14 i1="04"><s1>IRCCS CSS-Mendel Institute</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="05"><s1>Operative Unit of Pediatric Genetics and Immunology, Department of Medical and Surgical Pediatric Sciences, University of Messina</s1>
<s2>Messina</s2>
<s3>ITA</s3>
<sZ>3 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2007">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amplification</term>
<term>Gene rearrangement</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Parkinsonism</term>
<term>Simultaneous measurement</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Pathologie du système nerveux</term>
<term>Maladie de Parkinson</term>
<term>Parkinsonisme</term>
<term>Amplification</term>
<term>Mesure simultanée</term>
<term>Réarrangement génique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">:Parkinson's disease (PD) is a common disorder caused by degeneration of dopaminergic neurons in the substantia nigra and other brain areas. Mutations in several genes have been associated with both autosomal dominant PD and recessive early onset Parkinsonism (EOP). Genomic rearrangements such as deletions or multiplications of one or more exons represent a common mutational mechanism for most of these genes and are not detectable with routine mutation screening techniques. MLPA (Multiplex Ligation-dependent Probe Amplification), is a cheap, simple, rapid, and sensitive tool to detect exon dosage alterations and specific point mutations in selected genes. We tested the recently developed PD-MLPA assay by using 13 positive control samples carrying known mutations in SNCA, LRRK2, Parkin, PINK1, and DJ-1 genes. We then applied this technique to screen 16 EOP patients who were then cross-tested by quantitative PCR (qPCR). All the mutations present in the positive control samples were clearly detected by MLPA. Moreover, three novel Parkin rearrangements were identified among EOP patients and confirmed by qPCR. Only two samples generated false positive duplications of LRRK2 exon 1 and UCH-L1 exon 9, respectively. These results show that PD-MLPA assay can simultaneously and effectively detect rearrangements in most PD genes (SNCA, Parkin, PINK1, and DJ-1) as well as the LRRK2 G2019S common mutation. Thus, the use of this novel platform can improve the analysis of such mutations, facilitating comprehensive genetic testing in PD and EOP.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>22</s2>
</fA05>
<fA06><s2>15</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Multiplex Ligation-Dependent Probe Amplification Assay for Simultaneous Detection of Parkinson's Disease Gene Rearrangements</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>SCARCIOLLA (Oronzo)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>BRANCATI (Francesco)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>VALENTE (Enza Maria)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>FERRARIS (Alessandro)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>VITTORIA DE ANGELIS (Maria)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>VALBONESI (Stefano)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>GARAVAGLIA (Barbara)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>UNCINI (Antonino)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>PALKA (Giandomenico)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>STUPPIA (Liborio)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>DALLAPICCOLA (Bruno)</s1>
</fA11>
<fA14 i1="01"><s1>Aging Research Center, CeSi, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Department of Biomedical Sciences, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Clinical Sciences and Bioimaging, University G. d'Annunzio</s1>
<s2>Chieti-Pescara</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>IRCCS CSS-Mendel Institute</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Operative Unit of Pediatric Genetics and Immunology, Department of Medical and Surgical Pediatric Sciences, University of Messina</s1>
<s2>Messina</s2>
<s3>ITA</s3>
<sZ>3 aut.</sZ>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Department of Experimental Medicine and Pathology, University La Sapienza</s1>
<s2>Rome</s2>
<s3>ITA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>Neurodegenerative Diseases Unit, Aging Research Center, CeSi, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="08"><s1>Department of Human Motor Sciences, University G. d'Annunzio</s1>
<s2>Chieti</s2>
<s3>ITA</s3>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="09"><s1>Molecular Neurogenetics Unit, Foundation IRCCS Neurological Institute "C. Besta"</s1>
<s2>Milan</s2>
<s3>ITA</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="10"><s1>Human Genetics Division, Hospital of Pescara</s1>
<s2>Pescara</s2>
<s3>ITA</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="11"><s1>IGM CNR</s1>
<s2>Bologna</s2>
<s3>ITA</s3>
<sZ>10 aut.</sZ>
</fA14>
<fA20><s1>2274-2278</s1>
</fA20>
<fA21><s1>2007</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000162671070210</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2008 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>13 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>08-0071417</s0>
</fA47>
<fA60><s1>P</s1>
<s3>CC</s3>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>:Parkinson's disease (PD) is a common disorder caused by degeneration of dopaminergic neurons in the substantia nigra and other brain areas. Mutations in several genes have been associated with both autosomal dominant PD and recessive early onset Parkinsonism (EOP). Genomic rearrangements such as deletions or multiplications of one or more exons represent a common mutational mechanism for most of these genes and are not detectable with routine mutation screening techniques. MLPA (Multiplex Ligation-dependent Probe Amplification), is a cheap, simple, rapid, and sensitive tool to detect exon dosage alterations and specific point mutations in selected genes. We tested the recently developed PD-MLPA assay by using 13 positive control samples carrying known mutations in SNCA, LRRK2, Parkin, PINK1, and DJ-1 genes. We then applied this technique to screen 16 EOP patients who were then cross-tested by quantitative PCR (qPCR). All the mutations present in the positive control samples were clearly detected by MLPA. Moreover, three novel Parkin rearrangements were identified among EOP patients and confirmed by qPCR. Only two samples generated false positive duplications of LRRK2 exon 1 and UCH-L1 exon 9, respectively. These results show that PD-MLPA assay can simultaneously and effectively detect rearrangements in most PD genes (SNCA, Parkin, PINK1, and DJ-1) as well as the LRRK2 G2019S common mutation. Thus, the use of this novel platform can improve the analysis of such mutations, facilitating comprehensive genetic testing in PD and EOP.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17G</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B17A03</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Pathologie du système nerveux</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Maladie de Parkinson</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Parkinsonisme</s0>
<s2>NM</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Parkinsonism</s0>
<s2>NM</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Parkinson síndrome</s0>
<s2>NM</s2>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Amplification</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Amplification</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Amplificación</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Mesure simultanée</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Simultaneous measurement</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Medición simultánea</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Réarrangement génique</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Gene rearrangement</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Redisposición génica</s0>
<s5>11</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Pathologie de l'encéphale</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Syndrome extrapyramidal</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Pathologie du système nerveux central</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fN21><s1>035</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 08-0071417 INIST</NO>
<ET>Multiplex Ligation-Dependent Probe Amplification Assay for Simultaneous Detection of Parkinson's Disease Gene Rearrangements</ET>
<AU>SCARCIOLLA (Oronzo); BRANCATI (Francesco); VALENTE (Enza Maria); FERRARIS (Alessandro); VITTORIA DE ANGELIS (Maria); VALBONESI (Stefano); GARAVAGLIA (Barbara); UNCINI (Antonino); PALKA (Giandomenico); STUPPIA (Liborio); DALLAPICCOLA (Bruno)</AU>
<AF>Aging Research Center, CeSi, University G. d'Annunzio/Chieti/Italie (1 aut., 2 aut., 6 aut., 9 aut., 10 aut.); Department of Biomedical Sciences, University G. d'Annunzio/Chieti/Italie (1 aut., 2 aut., 6 aut., 9 aut., 10 aut.); Department of Clinical Sciences and Bioimaging, University G. d'Annunzio/Chieti-Pescara/Italie (1 aut.); IRCCS CSS-Mendel Institute/Rome/Italie (2 aut., 3 aut., 4 aut., 11 aut.); Operative Unit of Pediatric Genetics and Immunology, Department of Medical and Surgical Pediatric Sciences, University of Messina/Messina/Italie (3 aut., 11 aut.); Department of Experimental Medicine and Pathology, University La Sapienza/Rome/Italie (4 aut.); Neurodegenerative Diseases Unit, Aging Research Center, CeSi, University G. d'Annunzio/Chieti/Italie (5 aut., 8 aut.); Department of Human Motor Sciences, University G. d'Annunzio/Chieti/Italie (5 aut., 8 aut.); Molecular Neurogenetics Unit, Foundation IRCCS Neurological Institute "C. Besta"/Milan/Italie (7 aut.); Human Genetics Division, Hospital of Pescara/Pescara/Italie (9 aut.); IGM CNR/Bologna/Italie (10 aut.)</AF>
<DT>Publication en série; Courte communication, note brève; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2007; Vol. 22; No. 15; Pp. 2274-2278; Bibl. 13 ref.</SO>
<LA>Anglais</LA>
<EA>:Parkinson's disease (PD) is a common disorder caused by degeneration of dopaminergic neurons in the substantia nigra and other brain areas. Mutations in several genes have been associated with both autosomal dominant PD and recessive early onset Parkinsonism (EOP). Genomic rearrangements such as deletions or multiplications of one or more exons represent a common mutational mechanism for most of these genes and are not detectable with routine mutation screening techniques. MLPA (Multiplex Ligation-dependent Probe Amplification), is a cheap, simple, rapid, and sensitive tool to detect exon dosage alterations and specific point mutations in selected genes. We tested the recently developed PD-MLPA assay by using 13 positive control samples carrying known mutations in SNCA, LRRK2, Parkin, PINK1, and DJ-1 genes. We then applied this technique to screen 16 EOP patients who were then cross-tested by quantitative PCR (qPCR). All the mutations present in the positive control samples were clearly detected by MLPA. Moreover, three novel Parkin rearrangements were identified among EOP patients and confirmed by qPCR. Only two samples generated false positive duplications of LRRK2 exon 1 and UCH-L1 exon 9, respectively. These results show that PD-MLPA assay can simultaneously and effectively detect rearrangements in most PD genes (SNCA, Parkin, PINK1, and DJ-1) as well as the LRRK2 G2019S common mutation. Thus, the use of this novel platform can improve the analysis of such mutations, facilitating comprehensive genetic testing in PD and EOP.</EA>
<CC>002B17; 002B17G; 002B17A03</CC>
<FD>Pathologie du système nerveux; Maladie de Parkinson; Parkinsonisme; Amplification; Mesure simultanée; Réarrangement génique</FD>
<FG>Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du système nerveux central</FG>
<ED>Nervous system diseases; Parkinson disease; Parkinsonism; Amplification; Simultaneous measurement; Gene rearrangement</ED>
<EG>Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease</EG>
<SD>Sistema nervioso patología; Parkinson enfermedad; Parkinson síndrome; Amplificación; Medición simultánea; Redisposición génica</SD>
<LO>INIST-20953.354000162671070210</LO>
<ID>08-0071417</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001444 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001444 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PascalFrancis |étape= Corpus |type= RBID |clé= Pascal:08-0071417 |texte= Multiplex Ligation-Dependent Probe Amplification Assay for Simultaneous Detection of Parkinson's Disease Gene Rearrangements }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |